Literature DB >> 11585982

Cytochrome P450 3A expression in the human fetal liver: evidence that CYP3A5 is expressed in only a limited number of fetal livers.

J Hakkola1, H Raunio, R Purkunen, S Saarikoski, K Vähäkangas, O Pelkonen, R J Edwards, A R Boobis, M Pasanen.   

Abstract

CYP3A is the major cytochrome P450 subfamily constitutively expressed in the human liver. CYP3A4 is the predominant hepatic P450 form in adults and it is expressed at high but very variable levels among individuals. The fetal liver contains mainly CYP3A7, while the presence of the other CYP3A enzymes in fetal liver has remained controversial. In this study, the relative levels of CYP3A4, CYP3A5 and CYP3A7 expression were determined in a panel of 9-11 fetal livers with a similar gestation age (9-12 weeks) and compared to adult livers. CYP3A7 was found to be the major CYP3A form in all the fetal liver samples. The abundance of CYP3A7 varied more at the mRNA (77-fold variation) than at the protein level (4.8-fold variation). CYP3A5 mRNA was also detected in all of the fetal liver samples, but the average level was 700-fold lower than that of CYP3A7. CYP3A5 protein was detected by immunoblot analysis in only 1 fetal liver out of the 9 investigated, the level of expression being moderately high in this sample. CYP3A4 mRNA was detected in only a subset of the fetal liver samples and its level was the lowest of the CYP3A forms. This is the first study to demonstrate the polymorphic expression of CYP3A5 and the variability of CYP3A7 expression in fetal liver and suggests that significant interindividual differences in the metabolism of xenobiotics may already exist at the prenatal stage. These differences may contribute to individual pharmacological and/or toxicological responses in the fetus. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585982     DOI: 10.1159/000047142

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  13 in total

1.  Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting.

Authors:  Xuanyi Ma; Xin Qu; Wei Zhu; Yi-Shuan Li; Suli Yuan; Hong Zhang; Justin Liu; Pengrui Wang; Cheuk Sun Edwin Lai; Fabian Zanella; Gen-Sheng Feng; Farah Sheikh; Shu Chien; Shaochen Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 2.  Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.

Authors:  Lina Schiffer; Lise Barnard; Elizabeth S Baranowski; Lorna C Gilligan; Angela E Taylor; Wiebke Arlt; Cedric H L Shackleton; Karl-Heinz Storbeck
Journal:  J Steroid Biochem Mol Biol       Date:  2019-07-27       Impact factor: 4.292

3.  Identification of CYP3A7 for glyburide metabolism in human fetal livers.

Authors:  Diana L Shuster; Linda J Risler; Bhagwat Prasad; Justina C Calamia; Jenna L Voellinger; Edward J Kelly; Jashvant D Unadkat; Mary F Hebert; Danny D Shen; Kenneth E Thummel; Qingcheng Mao
Journal:  Biochem Pharmacol       Date:  2014-10-22       Impact factor: 5.858

Review 4.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.

Authors:  Khaled Abduljalil; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 5.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

6.  CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation.

Authors:  Hamid Zia; Graeme I Murray; Carrie A Vyhlidal; J Steven Leeder; Ahmed E Anwar; Marilyn M Bui; Atif A Ahmed
Journal:  Int J Exp Pathol       Date:  2015-02-09       Impact factor: 1.925

Review 7.  PharmVar GeneFocus: CYP3A5.

Authors:  Cristina Rodriguez-Antona; Jessica L Savieo; Volker M Lauschke; Katrin Sangkuhl; Britt I Drögemöller; Danxin Wang; Ron H N van Schaik; Andrei A Gilep; Arul P Peter; Erin C Boone; Bronwyn E Ramey; Teri E Klein; Michelle Whirl-Carrillo; Victoria M Pratt; Andrea Gaedigk
Journal:  Clin Pharmacol Ther       Date:  2022-02-24       Impact factor: 6.903

8.  Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.

Authors:  Shringi Sharma; Ewa C S Ellis; Kenneth Dorko; Shimin Zhang; Donald R Mattison; Steve N Caritis; Raman Venkataramanan; Stephen C Strom
Journal:  Drug Metab Dispos       Date:  2010-01-22       Impact factor: 3.922

Review 9.  Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.

Authors:  Ibrahim Ince; Catherijne A J Knibbe; Meindert Danhof; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

10.  Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues.

Authors:  Joshua F Robinson; Emily G Hamilton; Juleen Lam; Hao Chen; Tracey J Woodruff
Journal:  Placenta       Date:  2020-08-06       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.